Shopping Cart 0
Cart Subtotal
USD 0

Clinigen Group Plc (CLIN) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 300

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 600

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 900
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Clinigen Group Plc (Clinigen Group) is a pharmaceutical and services company that provides access to clinical trials, medicines, unlicensed and commercial supply. The company acquires and licenses essential commercial medicines such as foscavir, cardioxane, ethyol, savene and vibativ. It offers clinical trial services, global access, IDIS managed access, and strategic services. Clinigen Group's clinical trial services comprise demand-driven labelling and distribution, direct-to-site delivery, ancillary supply, investigator-initiated trial services, and technical consultancy services. It serves biotechnology and pharmaceutical companies, and healthcare professionals. The company has its operations in Japan, the US, New Zealand, Australia, Singapore, South Africa, and the UK. Clinigen Group is headquartered in Burton-on-Trent, the UK.

Clinigen Group Plc Key Recent Developments

Feb 27,2019: Clinigen Group: Good H1 performance with adjusted EPS up 9% and strong cash flow

Feb 05,2019: Clinigen Group names Nick Keher as Group Chief Financial Officer

Jan 15,2019: Clinigen Group: Half Year trading update

Jan 10,2019: Clinigen extends exclusive European clinical trial sourcing and supply agreement with Accord Healthcare

Nov 15,2018: Clinigen Group: Board appointment

This comprehensive SWOT profile of Clinigen Group Plc provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData's 'Profile on Demand' service, covering over 50,000 of the world's leading companies. Once purchased, GlobalData's highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Clinigen Group Plc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

READ MORE

Table Of Content

Scope

Table of Contents

Section 1-About the Company

Clinigen Group Plc-Key Information

Clinigen Group Plc-Overview

Clinigen Group Plc-Key Employees

Clinigen Group Plc-Key Employee Biographies

Clinigen Group Plc-Key Operational Heads

Clinigen Group Plc-Major Products and Services

Clinigen Group Plc-History

Clinigen Group Plc-Company Statement

Clinigen Group Plc-Locations And Subsidiaries

Clinigen Group Plc-Key Manufacturing facilities

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Clinigen Group Plc-Business Description

Clinigen Group Plc-Corporate Strategy

Clinigen Group Plc-SWOT Analysis

SWOT Analysis-Overview

Clinigen Group Plc-Strengths

Clinigen Group Plc-Weaknesses

Clinigen Group Plc-Opportunities

Clinigen Group Plc-Threats

Clinigen Group Plc-Key Competitors

Section 3-Company Financial Performance Charts

Clinigen Group Plc-Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Appendix

Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

Note*: Some sections may be missing if data is unavailable for the company


List Of Figure

List of Figures

Clinigen Group Plc, Performance Chart

Clinigen Group Plc, Ratio Charts


List Of Table

List of Tables

Clinigen Group Plc, Key Information

Clinigen Group Plc, Key Ratios

Clinigen Group Plc, Share Data

Clinigen Group Plc, Major Products and Services

Clinigen Group Plc, History

Clinigen Group Plc, Key Employees

Clinigen Group Plc, Key Employee Biographies

Clinigen Group Plc, Key Operational Heads

Clinigen Group Plc, Other Locations

Clinigen Group Plc, Subsidiaries

Clinigen Group Plc, Key Manufacturing facilities

Clinigen Group Plc, Key Competitors

Clinigen Group Plc, SWOT Analysis

Clinigen Group Plc, Ratios based on current share price

Clinigen Group Plc, Annual Ratios

Clinigen Group Plc, Interim Ratios

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Clinigen Group Plc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History, Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts